A detailed history of Aveo Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aveo Capital Partners, LLC holds 8,545 shares of PFE stock, worth $225,246. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,545
Previous 8,020 6.55%
Holding current value
$225,246
Previous $224,000 10.27%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $14,542 - $16,479
525 Added 6.55%
8,545 $247,000
Q2 2024

Aug 02, 2024

SELL
$25.26 - $29.6 $77,270 - $90,546
-3,059 Reduced 27.61%
8,020 $224,000
Q1 2024

May 06, 2024

SELL
$25.89 - $29.73 $906 - $1,040
-35 Reduced 0.31%
11,079 $307,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $387,455 - $503,262
-14,828 Reduced 57.16%
11,114 $319,000
Q3 2023

Nov 06, 2023

SELL
$32.09 - $37.51 $22,463 - $26,257
-700 Reduced 2.63%
25,942 $860,000
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $15,748 - $18,220
436 Added 1.66%
26,642 $977,000
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $237,285 - $308,910
-6,024 Reduced 18.69%
26,206 $1.07 Million
Q4 2022

Feb 03, 2023

BUY
$41.75 - $54.5 $86,547 - $112,978
2,073 Added 6.87%
32,230 $1.65 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $274,156 - $334,676
6,265 Added 26.22%
30,157 $1.32 Million
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $38,340 - $45,460
-824 Reduced 3.33%
23,892 $1.25 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $96,669 - $119,785
-2,113 Reduced 7.88%
24,716 $1.28 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $689,258 - $1.02 Million
16,681 Added 164.38%
26,829 $1.58 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $21,195 - $27,226
-540 Reduced 5.05%
10,148 $436,000
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $2,405 - $2,725
67 Added 0.63%
10,688 $419,000
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $355,697 - $401,155
10,621 New
10,621 $385,000
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $276,194 - $351,205
-8,252 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $262,001 - $307,387
8,252 New
8,252 $303,000
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $215,207 - $261,078
-7,145 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $11,271 - $16,104
417 Added 6.2%
7,145 $233,000
Q4 2019

Feb 06, 2020

BUY
$32.92 - $37.36 $21,825 - $24,769
663 Added 10.93%
6,728 $264,000
Q3 2019

Nov 07, 2019

BUY
$32.49 - $42.13 $2,761 - $3,581
85 Added 1.42%
6,065 $231,000
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $961 - $1,079
-26 Reduced 0.43%
5,980 $256,000
Q1 2019

May 07, 2019

SELL
$37.5 - $41.2 $4,575 - $5,026
-122 Reduced 1.99%
6,006 $255,000
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $115 - $131
-3 Reduced 0.05%
6,128 $267,000
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $123,643 - $149,972
-3,587 Reduced 36.91%
6,131 $272,000
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $4,056 - $4,324
-123 Reduced 1.25%
9,718 $353,000
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $47,450 - $55,048
1,487 Added 17.8%
9,841 $349,000
Q4 2017

Feb 05, 2018

SELL
$33.26 - $35.29 $19,024 - $20,185
-572 Reduced 6.41%
8,354 $303,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $276,706 - $304,822
8,926
8,926 $319,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Aveo Capital Partners, LLC Portfolio

Follow Aveo Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aveo Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aveo Capital Partners, LLC with notifications on news.